YCBD Stock Analysis: Buy, Sell, or Hold?
YCBD - cbdMD, Inc. Common Stock
$0.77
-0.04 (-5.32%)
▼
5d:
-8.67%
30d:
+2.7%
90d:
+9.41%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 21, 2026
4d
Get Alerted When YCBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: YCBD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: YCBD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: YCBD is currently trading at $0.77, which is considered slightly low relative to its 30-day fair value range of $0.73 to $0.91.
Technical Outlook: Technically, YCBD is in a downtrend. Immediate support is located at $0.71, while resistance sits at $0.92. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+160.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, YCBD is in a downtrend. Immediate support is located at $0.71, while resistance sits at $0.92. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+160.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.73 -
$0.91
Company Quality Score
44/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-5.3%)
- BULLISH: Trading 160.7% below Wall St target ($2.00)
- CAUTION: Recommendation downgraded due to -8.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.73 -
$0.91
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$0.92
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.96
Wall Street Target
$2.00
(+160.7%)
Revenue Growth (YoY)
-1.9%
Profit Margin
-12.2%
Share & Embed Analysis
Last updated: May 15, 2026 10:26 PM ET
Data refreshes hourly during market hours. Next update: 11:26 PM
Data refreshes hourly during market hours. Next update: 11:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YCBD showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$136 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$102 | 59 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
